NASDAQ:JSPR

Jasper Therapeutics Stock Forecast

etoro logo Buy JSPR
*Your capital is at risk
$0.489
-0.0125 (-2.49%)
At Close: Jun 23, 2026
AI Analysis AI Analysis of JSPR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add JSPR to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Jasper Therapeutics, Inc. stock downgraded to Strong Sell Candidate
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 27, 2026 Loss -45.81%

The Jasper Therapeutics, Inc. stock price fell by -2.49% on the last day (Tuesday, 23rd Jun 2026) from $0.502 to $0.489. During the last trading day the stock fluctuated 6.63% from a day low at $0.469 to a day high of $0.500. The price has been going up and down for this period, and there has been a 6.07% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 647 thousand shares were bought and sold for approximately $316.33 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.55% during the next 3 months and, with a 90% probability hold a price between $0.140 and $0.412 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

JSPR Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 8.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Jasper Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.711. On a fall, the stock will find some support from the short-term average at $0.472. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Jasper Therapeutics, Inc. stock

Jasper Therapeutics, Inc. finds support from accumulated volume at $0.481 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0311 between high and low, or 6.63%. For the last week the stock has had daily average volatility of 13.22%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (JSPR) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Jasper Therapeutics, Inc. to open at $0.486, and during the day (based on 14 day Average True Range), to move between $0.450 and $0.528, which gives a possible trading interval of +/-$0.0774 (+/-17.18%) up or down from last closing price. If Jasper Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.481 (1.57%) than the resistance at $0.502 (2.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Jasper Therapeutics, Inc. stock A Buy?

Jasper Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.234 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.486 ( 0.620%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

JSPR Performance

Trading levels for JSPR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.517 5.74%
R2 0.505 3.31%
R1 0.498 1.81%
Price 0.489
S1 0.474 -3.05%
S2 0.467 -4.55%
S3 0.455 -6.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.551 12.74%
R2 0.534 9.24%
R1 0.502 2.56%
Price 0.489
S1 0.481 -1.57%
S2 0.466 -4.70%
S3 0.461 -5.73%

FAQ

What is the symbol for Jasper Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Jasper Therapeutics, Inc. is JSPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Jasper Therapeutics, Inc. Stock?
Jasper Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Jasper Therapeutics, Inc. Stock?
Jasper Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jasper Therapeutics, Inc. Stock.

What's the current price of Jasper Therapeutics, Inc. Stock?
As of the end of day on the Jun 23, 2026, the price of an Jasper Therapeutics, Inc. (JSPR) share was $0.489.

What is the 52-week high and low for Jasper Therapeutics, Inc. Stock?
The 52-week high for Jasper Therapeutics, Inc. Stock is $7.19 and the 52-week low is $0.420.

What is the market capitalization of Jasper Therapeutics, Inc. Stock?
As of the Jun 23, 2026, the market capitalization of Jasper Therapeutics, Inc. is 7.948M.

When is the next earnings date for Jasper Therapeutics, Inc.?
The upcoming earnings date for Jasper Therapeutics, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT JASPER THERAPEUTICS, INC.
Jasper Therapeutics
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The co...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
EAT
$140.46
16.94% Jun 05
E
ETD
$20.67
4.79% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE